Taro-Gliclazide MR 30 mg (Gliclazide TABLET (EXTENDED-RELEASE)) 30 MG

Taro-Gliclazide MR 30 mg is an extended-release tablet used to manage type 2 diabetes. It helps control blood sugar levels by improving insulin sensitivity. Buy Taro-Gliclazide MR online for convenient diabetes management.

Strength

30 MG

Manufacturer / TM Owner

SUN PHARMA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Taro-Gliclazide MR 30 mg is primarily used for the management of type 2 diabetes. It works by helping the body respond better to insulin, thereby lowering blood sugar levels. This medication is often prescribed as part of a broader treatment plan that includes diet and exercise. People often ask, 'What is Taro-Gliclazide MR used for?' It is designed to provide extended-release benefits, helping maintain stable blood sugar levels throughout the day.

Side Effects

Common effects of Taro-Gliclazide MR 30 mg may include dizziness, nausea, and headaches. Some users might experience hypoglycemia, characterized by symptoms like sweating, shakiness, and confusion. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Taro-Gliclazide MR 30 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Taro-Gliclazide MR 30 mg may interact with certain medications, including other diabetes drugs, blood pressure medications, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can enhance the risk of hypoglycemia. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Taro-Gliclazide MR 30 mg is used to manage type 2 diabetes by improving insulin sensitivity and controlling blood sugar levels.

Taro-Gliclazide MR 30 mg is an oral medication that should be taken as directed by a healthcare professional, typically once daily.

Common side effects may include dizziness, nausea, headaches, and symptoms of hypoglycemia such as sweating and shakiness.

Taro-Gliclazide MR may interact with other medications, so it is important to consult a healthcare professional before combining it with other drugs.

Taro-Gliclazide MR should be stored at room temperature, away from moisture and heat, to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.